LV

Lavanya Vemula

Active Director Director DIN 11081062
DIN 11081062 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Lavanya Vemula

Data last updated:

Lavanya Vemula is a Director at Clinbio Clinical Research Private Limited (since 2025). The company operates in Healthcare.

DIN 11081062
Primary Designation Director
Industry Healthcare
First Appointment 29 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Apr 20252025Active

Board colleagues of Lavanya Vemula

NameDINCompanyDesignation
Venkata Raveendra Babu Vemula11081063Clinbio Clinical Research Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Clinbio Clinical Research Private Limited
Premium access

Shareholding and investment profile for Lavanya Vemula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lavanya Vemula

Lavanya Vemula currently holds 1 directorship: Clinbio Clinical Research Private Limited (Director, since 29 Apr 2025).

Lavanya Vemula was first appointed on 29 Apr 2025 as Director at Clinbio Clinical Research Private Limited.

The current boards of Lavanya Vemula's companies include Venkata Raveendra Babu Vemula (Clinbio Clinical Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available